NDC 17856-0182-2 - ACETAMINOPHEN
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-0182
- Requested NDC
- 17856-0182-2
- Package NDCs from labels
- 17856-0182-2, 17856-0182-1, 17856-0182-3, 17856-0182-5, 17856-0182-4
- Manufacturer
- ATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONS
- Effective date
- 2022-11-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ACETAMINOPHEN - ATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONS | ATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONS | 2022-11-14 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 17856-0182-3 | 2024-01-30 | C162847 | 48780-1 | 1030e364-fb3f-111a-e063-dadaa90a10e2 | Acetaminophen Elxir Bubble Gum Flavor |
| 17856-0182-4 | 2024-01-30 | C162847 | 48780-1 | 1030e364-fb3f-111a-e063-dadaa90a10e2 | Acetaminophen Elxir Bubble Gum Flavor |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-0182-1 | ACETAMINOPHEN | 120 in 1 BOX, UNIT-DOSE | ELIXIR | 120 | 3 | |
| 17856-0182-2 | ACETAMINOPHEN | 2 mL in 1 SYRINGE | ELIXIR | 2 | 3 | |
| 17856-0182-3 | ACETAMINOPHEN | 5 in 1 SYRINGE | ELIXIR | 5 | 3 | |
| 17856-0182-4 | ACETAMINOPHEN | 72 in 1 BOX, UNIT-DOSE | ELIXIR | 72 | 3 | |
| 17856-0182-5 | ACETAMINOPHEN | 5 mL in 1 CUP, UNIT-DOSE | ELIXIR | 5 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-0182 | ACETAMINOPHEN ELIXIR [ATLANTIC BIOLOGICALS CORP.] | 3 | Legacy NDC, 5 package rows | 20221115_cf2dd95d-afea-462d-9dba-a46a68bf67e6.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 17856-0182-4 | ML - Milliliter | 17856-0182 | 095990e2-50ba-4bb4-a465-af7821d7ccb3 | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Extra Strength Night Time Pain Medicine | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | Geri-Care Pharmaceutical Corp | 2b8f83ed-1ca9-49ac-9b2a-2609b68200f9 | 2024-05-21 | Warnings | 362O9ITL9D |
| Acetaminophen Solution | ACETAMINOPHEN | Patrin Pharma, Inc. | 52ae729b-2255-420c-8db8-cabdc2b74796 | 2024-05-21 | Warnings | 307675 362O9ITL9D |
| Pain Reliever | ACETAMINOPHEN | QUALITY CHOICE (Chain Drug Marketing Association) | 2f9da3d6-229d-44d1-bd94-4bcddbbdb120 | 2024-05-20 | Warnings | 362O9ITL9D |
| Acetaminophen and Codeine Phosphate | ACETAMINOPHEN AND CODEINE PHOSPHATE | Strides Pharma Science Limited | c459ed02-afd6-4533-82b6-bfb2c7ab0e72 | 2024-05-20 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| AMAZON BASIC CARE ACETAMINOPHEN | ACETAMINOPHEN | Amazon.com Services LLC | 10ee2f40-858d-bed4-e063-6394a90a86bb | 2024-05-17 | Warnings | 362O9ITL9D |
| TYLENOL EXTRA STRENGTH | ACETAMINOPHEN | A-S Medication Solutions | bcb7eb24-16cb-439e-879f-48d2f5e8ba83 | 2024-05-17 | Warnings | 362O9ITL9D |
| Basic Care Childrens Pain and Fever | ACETAMINOPHEN | Amazon.com Services LLC | 26266777-185d-4110-a8a7-56846aab2542 | 2024-05-17 | Warnings | 362O9ITL9D |
| TYLENOL EXTRA STRENGTH | ACETAMINOPHEN | A-S Medication Solutions | 1b4db77f-b254-4db5-8e98-d46850140a9b | 2024-05-16 | Warnings | 362O9ITL9D |
| Tencon | BUTALBITAL AND ACETAMINOPHEN | El Dorado Distributors LLC | 4e4a9925-67aa-4be7-8bb7-c8b058ffe223 | 2024-05-15 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| KOSHER MEDS Childrens Pain and Fever | ACETAMINOPHEN | Mollec Inc | 4d01c9ee-26be-4cdd-b52d-7fa344c1933a | 2024-05-15 | Warnings | 362O9ITL9D |
| Cold and Flu Relief Nighttime | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE | Safeway, Inc. | d6ac0d70-0511-4ec8-bb35-8b2e0e3d7742 | 2024-05-15 | Warnings | 362O9ITL9D |
| Cold Flu and Sore Throat Relief Maximum Strength | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | Safeway, Inc. | 6c952c81-c8b6-4e74-abd8-781f6f44736b | 2024-05-14 | Warnings | 362O9ITL9D |
| Pain and Sinus Reliever | ACETAMINOPHEN AND PHENYLEPHRINE | JHK DBA American Safety & First Aid | 249373c6-f56f-4bd3-9cef-98b7ee73457d | 2024-05-14 | Warnings | 362O9ITL9D |
| Nighttime Cold and Flu Relief | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE | Safeway, Inc. | a70ead03-6d2c-44c1-9ae5-f6c4094821ec | 2024-05-14 | Warnings | 362O9ITL9D |
| Day Time Cold and Flu Relief non drowsy | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE | Safeway, Inc. | cc450f89-a156-48e0-82ae-19782f13c2ca | 2024-05-13 | Warnings | 362O9ITL9D |
| Cold and Flu DayTime | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE | Safeway, Inc. | ef0cd436-5e81-47a7-92d6-58495283ab28 | 2024-05-13 | Warnings | 362O9ITL9D |
| Pain Relief | ACETAMINOPHEN | P & L Development, LLC | 1c081a7c-8cff-4253-97ac-5fa74a5c0668 | 2024-05-10 | Warnings | 362O9ITL9D |
| Sodium Phenylacetate and Sodium Benzoate | SODIUM PHENYLACETATE AND SODIUM BENZOATE | FOSUN PHARMA USA INC | cee1e9a2-bbe5-2419-e053-2a95a90ac3ef | 2024-05-09 | Warnings, Adverse reactions | OJ245FE5EU |
| dg health childrens pain and fever | ACETAMINOPHEN | Dolgencorp Inc | 1d794621-9836-4ab8-92ee-fcd916964567 | 2024-05-09 | Warnings | 362O9ITL9D |
| Severe Cold and Flu Daytime | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | KROGER COMPANY | 10106c90-f2f0-508e-e063-6294a90a544b | 2024-05-08 | Warnings | 362O9ITL9D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.